Floragraph Decorating Ceremony Honored South Jersey Teen’s Life-Saving Organ Donation

Memorial floragraph will be among several adorning the 2019 Donate Life Float at the  130th Rose ParadeTM on January 1, 2019, in Pasadena, California.

Family, loved ones, hospital staff, and representatives from the NJ Sharing Network gathered on November 16, 2018  to remember Tabernacle, NJ, teen Sean Clegg by completing a beautiful floragraph portrait that will be part of the 2019 Donate Life Float at the 130th Annual Rose ParadeTM in Pasadena, California, this coming New Year’s Day. Read more.

Chairman George E. Norcross, III Announces Cooper University Health Care to Raise Minimum Wage to $15 an Hour for All Employees, Calls on Other Health Care Systems to Join Effort to Raise Wages

Wage Hike by Largest Employer in Camden City and County Will Benefit 10% of Workforce

Cooper University Health Care Chairman George E. Norcross, III today announced the health system will increase the minimum wage it pays employees to $15 an hour, the first health system in New Jersey to make such a commitment to its full-time, part-time, and per-diem employees. The new minimum wage policy will go into effect on January 1, 2019, and will benefit approximately 10 percent of Cooper’s 7,500 employees, one third of whom are Camden city residents and over 450 of whom are Camden County residents. Read more.

Cooper and Advanced Recovery Systems Join Forces to Build a Facility Dedicated to Addiction Treatment and Recovery

Cooper University Health Care and Advanced Recovery Systems (ARS), which operates addiction and substance abuse treatment centers in five states, announced the joining of forces to form a partnership to provide addiction recovery services to patients in the region. Together, ARS and Cooper are building a state-of-the-art, $27 million, 90-bed inpatient treatment facility in Cherry Hill, New Jersey; the first of several planned treatment facilities in the region. Read more.

MD Anderson Cancer Center at Cooper Participating in Innovative Breast Cancer Study

Study explores if some patients may forego surgery after chemotherapy

MD Anderson Cancer Center at Cooper has joined a clinical research study to determine if certain breast cancer patients who respond positively to neoadjuvant systemic therapy can be treated without surgery. This study, done in conjunction with The University of Texas MD Anderson Cancer Center in Houston, is led by principal investigator Henry M. Read more.

Cooper University Health Care Among Select Hospitals in the U.S. to Treat Central Sleep Apnea With Newly Approved Device

Cooper University Health Care is one of only 24 sites in the United States currently treating patients with central sleep apnea (CSA) with a new implantable device to stimulate breathing. The remedē® System, developed by medical technology company Respicardia, Inc., received FDA-approval in 2017 and is the first commercially available device to treat CSA.

“CSA is a serious breathing disorder that disrupts the normal breathing pattern during sleep and negatively affects quality of life and overall cardiovascular health,” said John A. Read more.

MD Anderson Cancer Center at Cooper Approved by Society of Surgical Oncology to Establish a Breast Surgical Oncology Fellowship Program

MD Anderson Cancer Center at Cooper has received a three-year approval to establish a new Breast Surgical Oncology Fellowship Program by the Society of Surgical Oncology, one of fewer than 50 programs in the nation.

“Receiving approval from the Society of Surgical Oncology for this new fellowship affirms the quality of the curriculum and the faculty at MD Anderson at Cooper,” said Kristin L. Read more.

Results of First Large Multicenter Theragnostics Trial in Sepsis Led by Cooper University Health Care Researchers Published in Prestigious Journal of American Medical Association

Study failed to confirm benefit of novel treatment used in many countries worldwide

The results of a five-year,  international multicenter trial studying the efficacy of a “blood purification” technique to treat sepsis has been published today in The Journal of the American Medical Association, a leading medical journal. Cooper University Health Care was the flagship investigative center and also the coordinating center for the study. Read more.

Cooper University Health Care First in the Region to Implant Next-Generation WATCHMAN FLX(TM) Device

Cooper is one of approximately 40 sites in the United States and the only hospital in the Philadelphia region participating in a clinical trial for Boston Scientific’s WATCHMAN FLX™ device. The WATCHMAN FLX™ is the next generation of a potentially life-changing catheter-based (or non-surgically delivered) device designed to close the left atrial appendage in order to reduce the risk of stroke in certain patients with atrial fibrillation (AFib). Read more.

MD Anderson Cancer Center at Cooper Celebrates Five-Year Anniversary

MD Anderson Cancer Center at Cooper marked its five-year anniversary of serving the region at a celebration attended by elected officials, hospital leadership, and cancer survivors.

“This is another exciting day as MD Anderson at Cooper continues to transform cancer care for the people of South Jersey and the region,” said George E. Norcross III, Chairman of the Board of Trustees at Cooper University Health Care. Read more.

Subaru and the Leukemia & Lymphoma Society Deliver “Gestures of Hope” to Cancer Patients at MD Anderson Cancer Center at Cooper

Executives from Subaru of America’s corporate headquarters and the Leukemia & Lymphoma Society (LLS) delivered messages of hope and 100 specially made blankets to outpatients at MD Anderson at Cooper to help encourage patients and keep them warm as they continue their fight against cancer.

“This is such a generous and kind gesture from our friends from Subaru of America, and the Leukemia & Lymphoma Society,” said Adrienne Kirby, PhD, FACHE, Executive Chair and Chief Executive Officer at Cooper University Health Care. Read more.